Recruit Top Talent at the 2008 ISCT Annual Meeting
Are you interested in recruiting for a cell therapy-related position in your company or institution? The inaugural Cell Therapy News and ISCT Joint Job Posting program is the perfect opportunity to highlight your organization, profile open positions, and recruit highly qualified cell therapy professionals from a captive audience of cell therapy experts, including scientists, technologists, and business professionals.
Click here to participate in this program.
Scientists Uncover the Potential to Control Adult Stem Cells
Professor Cay Kielty, of The University of Manchester, describes how she and her team have uncovered a messaging system that instructs adult stem cells to contribute to tissue repair in response to chemical signals in the body.
Article
Discovery of Differences in Heart’s Precursor Cells May Advance Treatment Options
Researchers at the University of North Carolina at Chapel Hill’s School of Medicine have shown that not all heart cells are created equal; in response to one signal to differentiate, some will act, while others lie in wait.
Article
A Pacemaker Without Wires or Batteries
By inserting genes into rat heart cells growing in a dish, researchers were able to create a beating pattern that was faster and more regular than had been seen before.
Article
Stem Cells Offer Cartilage Repair Hope for Arthritis Sufferers
Scientists at Cardiff University have successfully identified stem cells within articular cartilage of adults, which have the ability to derive into chondrocytes – the cells that make up the body’s cartilage – in high enough numbers to make treatment a realistic possibility.
Article
Regulating Hematopoietic Stem Cell Homeostasis And Leukemogenesis
Researchers identify the c-Cbl protein as a critical repressor of hematopoietic stem cell self-renewal. In addition to establishing a key role for protein ubiquitylation in hematopoietic stem cell development, this finding posits c-Cbl as a potential target in research into stem cell engineering as well as cell-based leukemia treatments.
Article
ImmuneRegen Releases Results from The University of Medicine and Dentistry of New Jersey Study Confirming Homspera’s Adult Stem Cell Activity
ImmuneRegen BioSciences, Inc. recently announced Homspera’s ability to enhance formation of early-stage blood cells from adult hematopoietic stem cells.
Article
New Use of Stem Cells to Heal Lame Horses May Lead to Human Applications
Unencumbered by many of the prohibitions governing the use of stem cells in humans, veterinarians in Canada are speeding ahead with the latest developments to treat injured, high performance horses.
Article
New Technique Isolates Blood-Forming Stem Cells
In a recent publication, Saul Sharkis, a professor of oncology at the Hopkins medical school, has developed a novel method for isolating mouse hematopoietic stem cells, or blood-forming stem cells.
Article
Stratatech Completes Patient Enrollment in Phase I/II Clinical Trial
Stratatech Corporation has completed patient enrollment in a Phase I/II clinical trial to evaluate StrataGraft(TM) skin tissue in the temporary management of full-thickness skin wounds that require autografting.
Article
Pluristem’s PLX Cells Show a Statistically Significant Advantage in a Pre-Clinical Study in the Multiple Sclerosis Model
Pluristem Therapeutics Inc. announced recently that a preclinical study utilizing the Company’s placental eXpanded cells showed a statistically significant advantage in ameliorating functional deficiencies in a standard Multiple Sclerosis animal model. PLX cells are mesenchymal stromal cells obtained from the placenta and expanded using Pluristem’s proprietary 3D PluriX(TM) technology.
Article
University of Miami/Jackson Cardiologists Perform Groundbreaking Stem Cell Procedure on Heart Patient
Doctors performed a groundbreaking stem cell injection during triple-bypass surgery on the first man to participate in this new double-blind study.
Article
Encouraging Clinical Data Reported From Aastrom’s First EU Compassionate Use Cardiac Patients
Aastrom Biosciences recently announced encouraging data from the first two compassionate use patients treated with the Company’s autologous stem cell therapy for dilated cardiomyopathy, a type of severe chronic heart failure.
Article
Enrollment Completed for Investigator-Initiated Stem & Regenerative Cell Breast Augmentation Study in Japan
The study, which began November 2007, is evaluating a procedure whereby a woman’s fat tissue is enriched with her own adipose derived stem and regenerative cells to create a natural filler. This technique is referred to as ‘cell-enhanced reconstruction.’
Article
ABSTRACTS, REVIEWS AND SPECIAL REPORTS
Direct Reprogramming of Terminally Differentiated Mature B Lymphocytes to Pluripotency
A fundamental unresolved question with whether terminally differentiated cells can be reprogrammed to pluripotency. Their study provides definite proof for the direct nuclear reprogramming of terminally differentiated adult cells to pluripotency.
Article
JOB OPPORTUNITIES
Cellular Therapy Laboratory Manager
Center Valley, PA (Aesculap)
Link
Cellular Therapy Laboratory Manager
Seattle, WA (Seattle Cancer Care Alliance)
Link
Stem Cell Laboratory Medical Technologist
Saudi Arabia (National Guard Health Affairs)
Link
Stem Cell Laboratory Supervisor
Saudi Arabia (National Guard Health Affairs)
Link
Quality Management Supervisor
Saudi Arabia (National Guard Health Affairs)
Link
Medical Director
Tucson, AZ (Cbr Systems, Inc.)
Link